These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27580542)

  • 1. Usefulness of Magnetic Resonance Imaging for the Diagnosis of Hemochromatosis with Severe Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Nozaki Y; Sato N; Tajima T; Hasuo K; Kojima Y; Umemoto K; Mishima S; Mikami S; Nakayama T; Igari T; Akiyama J; Imamura M; Masaki N; Yanase M
    Intern Med; 2016; 55(17):2413-7. PubMed ID: 27580542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?
    Ajmera V; Loomba R
    Semin Liver Dis; 2018 Feb; 38(1):14-20. PubMed ID: 29471562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Differential Diagnosis of Liver Iron Contents in Nonalcoholic Steatohepatitis and Simple Steatosis Using Multiecho Dixon Magnetic Resonance Imaging.
    Kim TH; Jeong CW; Jun HY; Kim YR; Kim JY; Lee YH; Yoon KH
    Acad Radiol; 2019 Jun; 26(6):766-774. PubMed ID: 30143402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of diffuse liver disease. Hepatic fat and iron.
    Siegelman ES
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):347-65. PubMed ID: 9113679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsy.
    Boudinaud C; Abergel A; Joubert-Zakeyh J; Fontarensky M; Pereira B; Chauveau B; Garcier JM; Chabrot P; Boyer L; Magnin B
    Eur J Radiol; 2019 Sep; 118():169-174. PubMed ID: 31439237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy.
    Martín-Rodríguez JL; Arrebola JP; Jiménez-Moleón JJ; Olea N; González-Calvin JL
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):88-94. PubMed ID: 23921844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
    Pulli B; Wojtkiewicz G; Iwamoto Y; Ali M; Zeller MW; Bure L; Wang C; Choi Y; Masia R; Guimaraes AR; Corey KE; Chen JW
    Radiology; 2017 Aug; 284(2):390-400. PubMed ID: 28358240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
    de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
    J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 52-year-old man with liver enzyme abnormalities and elevated ferritin level.
    Nelsen EM; Newman DB; Sweetser S
    Mayo Clin Proc; 2012 Jan; 87(1):94-7. PubMed ID: 22212974
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple liver lesions of unusual benign etiology mimicking metastatic disease.
    Pais TP; Fernandes S; Fraga J
    Gastroenterology; 2014 Aug; 147(2):e10-1. PubMed ID: 24973686
    [No Abstract]   [Full Text] [Related]  

  • 13. Which clinical and sonographic parameters may be useful to discriminate NASH from steatosis?
    Zardi EM; De Sio I; Ghittoni G; Sadun B; Palmentieri B; Roselli P; Persico M; Caturelli E
    J Clin Gastroenterol; 2011 Jan; 45(1):59-63. PubMed ID: 20502351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease.
    Kang BK; Lee SS; Cheong H; Hong SM; Jang K; Lee MG
    Ultrasound Med Biol; 2015 Dec; 41(12):3205-15. PubMed ID: 26349582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy.
    Tovo CV; de Mattos AZ; Coral GP; Branco FS; Suwa E; de Mattos AA
    World J Gastroenterol; 2015 Apr; 21(15):4432-9. PubMed ID: 25914452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis.
    Ozenirler S; Erkan G; Konca Degertekin C; Ercin U; Cengiz M; Bilgihan A; Yilmaz G; Akyol G
    J Dig Dis; 2014 Mar; 15(3):131-6. PubMed ID: 24528633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
    Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
    J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents.
    Di Martino M; Pacifico L; Bezzi M; Di Miscio R; Sacconi B; Chiesa C; Catalano C
    World J Gastroenterol; 2016 Oct; 22(39):8812-8819. PubMed ID: 27818597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease: diagnosis and management.
    Wilkins T; Tadkod A; Hepburn I; Schade RR
    Am Fam Physician; 2013 Jul; 88(1):35-42. PubMed ID: 23939604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.